Clinical predictors of BRCA1/2 P/LP variants for high-risk breast cancer patients in China: HBRCA-risk prediction - Quiz - MDSpire

Clinical predictors of BRCA1/2 P/LP variants for high-risk breast cancer patients in China: HBRCA-risk prediction

  • By

  • Wei Gu

  • Chengyin Xu

  • Jinzhen Fu

  • Huijun Lei

  • Najeeb Ullah Khan

  • Ruijiao Lei

  • Xukai Chen

  • Xiao-jia Wang

  • Tianhui Chen

  • June 2, 2026

  • 0 min

Share

Original Source(s)

Clinical predictors of BRCA1/2 P/LP variants for high-risk breast cancer patients in China: HBRCA-risk prediction

  • by Wei Gu, Chengyin Xu, Jinzhen Fu, Huijun Lei, Najeeb Ullah Khan, Ruijiao Lei, Xukai Chen, Xiao-jia Wang, Tianhui Chen

  • June 2, 2026

Related Content

Roswell Park at ASCO 2026: GLP-1s and Aggressive Breast Cancer, CAR T in Older Adults, AI-Informed Benchmarking

The research findings of experts from Roswell Park Comprehensive Cancer Center will be featured during the American Society of Clinical Oncology (ASCO) annual meeting May 29 to June 2 at McCormick Place in Chicago

  • by

  • May 25, 2026

  • 9 min
Beyond the tumor: the role of the gut microbiome in triple-negative breast cancer

Overcoming immunotherapy resistance in triple-negative breast cancer: a critical review of mast cell plasticity, metabolic reprogramming, and organoid models